background
highli
pathogen
avian
influenza
hpai
viru
caus
multiorgan
diseas
death
poultri
result
signific
econom
loss
poultri
industri
addit
pose
major
public
health
threat
transmit
directli
infect
poultri
human
high
mortal
rate
effect
vaccin
hpai
would
protect
commerci
poultri
would
thu
provid
import
control
measur
reduc
likelihood
birdtobird
birdtohuman
transmiss
present
studi
evalu
vaccin
potenti
recombin
solubl
trimer
subtyp
hemagglutinin
produc
mammalian
cell
secret
purifi
biolog
activ
demonstr
bind
ligand
sialic
aciddepend
manner
shown
protect
chicken
dosedepend
manner
lethal
challeng
singl
vaccin
protect
anim
shed
challeng
viru
determin
quantit
rtpcr
rna
isol
trachea
cloaca
swab
also
mice
vaccin
provid
complet
protect
challeng
hpai
conclusionssignific
result
demonstr
constitut
attract
vaccin
antigen
protect
chicken
mammal
hpai
recombin
solubl
hemagglutinin
prepar
produc
high
yield
rel
short
lead
time
enabl
rapid
respons
circul
potenti
pandem
influenza
virus
citat
cornelissen
lahm
de
vri
rp
de
boerluijtz
ea
rigter
rottier
pjm
et
al
singl
immun
solubl
recombin
trimer
hemagglutinin
protect
chicken
highli
pathogen
avian
influenza
viru
plo
one
influenza
virus
envelop
negativestrand
rna
virus
segment
genom
infect
larg
varieti
anim
speci
although
bird
consid
constitut
reservoir
influenza
virus
speci
origin
basi
antigen
properti
two
surfac
glycoprotein
hemagglutinin
ha
neuraminidas
na
influenza
virus
classifi
ha
na
subtyp
highli
pathogen
avian
influenza
hpai
viru
caus
multiorgan
diseas
death
poultri
result
signific
econom
loss
poultri
industri
hpai
also
pose
major
public
health
threat
transmit
directli
infect
poultri
human
high
mortal
rate
wide
accept
continu
human
exposur
influenza
virus
circul
wild
domest
avian
speci
pose
perman
pandem
threat
effect
vaccin
hpai
would
protect
commerci
poultri
would
thu
provid
import
control
measur
reduc
likelihood
birdtobird
well
birdtohuman
transmiss
therefor
develop
efficaci
influenza
vaccin
high
veterinari
public
health
import
convent
vaccin
prepar
hpai
produc
propag
viru
embryon
chicken
egg
mammalian
cell
vaccin
virus
use
either
reassort
low
pathogen
wildtyp
avian
virus
either
way
virus
need
select
abil
multipli
egg
cultur
cell
may
preclud
best
genet
match
circul
hpai
strain
addit
vaccin
sever
limit
review
elsewher
henc
vaccin
strategi
hpai
explor
includ
use
among
other
live
attenu
influenza
vaccin
live
vaccin
base
heterolog
viral
vector
pox
viru
adenoviru
baculoviru
newcastl
diseas
viru
dna
vaccin
differ
strategi
often
show
promis
result
applic
ultim
depend
variou
import
issu
includ
safeti
efficaci
product
cost
protect
immun
influenza
viru
infect
diseas
primarili
confer
ha
via
induct
antiha
antibodi
protect
influenza
viru
infect
correl
antiha
titer
nearli
vaccin
approach
aim
induc
high
level
thereof
therefor
ha
protein
antigen
choic
develop
recombin
subunit
vaccin
protect
hpai
influenza
vaccin
base
recombin
purifi
ha
could
offer
follow
advantag
ha
antigen
produc
use
safe
qualitycontrol
scalabl
condit
ii
need
viru
cultiv
thu
avoid
necess
obtain
virus
replic
effici
egg
cell
cultur
b
use
biocontain
facil
c
inactiv
viru
use
procedur
may
affect
antigen
rais
safeti
concern
iii
recombin
ha
protein
highli
purifi
therebi
limit
advers
reaction
caus
eg
presenc
egg
contamin
iv
immun
recombin
ha
allow
serolog
differenti
natur
infect
vaccin
animalsflock
socal
diva
principl
iv
recombin
ha
vaccin
manufactur
rel
short
lead
time
allow
acceler
respons
emerg
influenza
strain
recombin
ha
produc
use
differ
express
system
express
e
coli
result
ha
protein
gave
rise
induct
hemagglutin
inhibit
hi
titer
upon
immun
mice
howev
proper
fold
trimer
ha
protein
requir
multipl
posttransl
modif
includ
glycosyl
disulfid
bond
format
express
ha
protein
higher
eukaryot
system
like
result
superior
antigen
thu
mammalian
cellderiv
ha
trimer
found
induc
much
higher
level
neutral
antibodi
similarli
produc
monomer
ha
protein
baculoviru
express
system
use
produc
strain
specif
ha
antigen
insect
cell
shown
protect
hpai
challeng
fullsiz
ha
protein
may
howev
limit
efficaci
membran
protein
may
retain
nativ
membranebound
structur
upon
purif
henc
product
recombin
solubl
stabl
ha
trimer
secret
cell
seem
like
attract
altern
approach
ha
trimer
express
either
insect
mammalian
cell
inde
shown
elicit
neutral
antibodi
partial
protect
mice
hpai
challeng
infect
view
promis
potenti
evalu
recombin
solubl
ha
trimer
chicken
mice
abil
induc
protect
immun
infect
hpai
end
recombin
solubl
protein
provid
trimer
motif
streptag
ii
latter
purif
purpos
express
mammalian
cell
recombin
solubl
trimer
purifi
cultur
supernat
use
simpl
onestep
purif
protocol
character
respect
oligomer
state
bioactiv
subsequ
vaccin
prepar
shown
provid
complet
protect
challeng
hpai
mice
chicken
latter
alreadi
singl
immun
cdna
clone
correspond
residu
number
ha
aviet
genbank
access
synthes
use
humanpref
codon
genscript
usa
inc
clone
predict
ha
ectodomain
protein
lack
multibas
cleavag
site
cdna
clone
express
vector
effici
express
mammalian
cell
vector
modifi
haencod
cdna
clone
frame
dna
sequenc
code
signal
sequenc
artifici
isoleucin
zipper
trimer
motif
krmkqiedkieeieskqkkieneiarikk
streptag
ii
wshpqfek
iba
germani
result
vector
encod
solubl
trimer
protein
design
express
vector
contain
ha
ectodomainencod
sequenc
transfect
gnti
cell
use
polyethyleneimin
pei
ratio
mg
dna
mg
pei
h
post
transfect
transfect
mixtur
replac
sfm
ii
express
medium
invitrogen
supplement
sodium
bicarbon
gliter
glucos
gliter
primaton
rluf
gliter
penicillin
unitsml
streptomycin
mgml
glutamax
gibco
dimethyl
sulfoxid
tissu
cultur
supernat
harvest
day
post
transfect
ha
protein
express
secret
confirm
sodium
dodecylsulf
sd
polyacrylamid
gel
electrophoresi
page
follow
western
blot
use
mous
antistreptag
antibodi
iba
germani
ha
protein
purifi
use
streptactin
sepharos
bead
accord
manufactur
instruct
iba
germani
concentr
purifi
protein
determin
use
nanodrop
spectrophotomet
isogen
life
scienc
accord
manufactur
instruct
oligomer
statu
protein
determin
analyz
elut
profil
use
column
ge
healthcar
sialic
acidbind
activ
assess
use
fetuin
solid
phase
assay
mgml
fetuin
per
well
use
coat
nunc
maxisorp
plate
indic
figur
legend
fetuin
treat
vibrio
cholera
deriv
neuraminidas
vcna
roch
follow
three
wash
step
precomplex
horseradish
peroxidas
hrp
link
antistreptag
antibodi
molar
ratio
min
prior
incub
limit
dilut
fetuinco
plate
min
room
temperatur
rt
habind
subsequ
detect
use
tetramethylbenzidin
substrat
biofx
elisa
reader
biotek
read
od
nm
anim
studi
conduct
central
veterinari
institut
cvi
lelystad
condit
approv
anim
ethic
committe
first
chicken
experi
week
old
spf
white
leghorn
chicken
lohmann
cuxhaven
germani
use
chicken
per
group
one
group
anim
immun
twice
day
intramuscular
im
inject
ml
mg
next
experi
onedayold
layer
hen
white
leghorn
purchas
local
breeder
chicken
vaccin
newcastl
diseas
viru
infecti
bronchiti
viru
age
one
day
accord
farm
routin
rais
cvi
anim
facil
age
week
bird
transport
facil
alloc
experiment
group
bird
anim
six
group
immun
day
twice
day
im
inject
mg
antigen
adjuv
stimun
immun
twice
dose
given
day
challeng
control
one
group
mockvaccin
twice
day
pb
stimun
four
week
vaccin
day
blood
sampl
taken
chicken
challeng
observ
daili
clinic
sign
day
trachea
cloaca
swab
taken
chicken
day
pi
femal
specifi
pathogenfre
spf
balbc
mice
charl
river
laboratori
anim
per
group
immun
day
twice
day
im
inject
ml
mg
adjuv
stimun
challeng
control
one
group
mice
mock
vaccin
three
week
vaccin
mice
anaesthet
ketaminxylazin
intraperiton
inject
inocul
intranas
ml
contain
median
lethal
dose
ld
log
tcid
provid
dr
alan
hay
influenza
centr
nation
institut
medic
research
london
mice
weigh
daili
examin
sign
ill
next
day
clinic
sign
record
use
score
system
clinic
sign
rough
coat
rough
coat
less
reactiv
passiv
handl
rough
coat
roll
labour
breath
passiv
handl
rough
coat
roll
labour
breath
unrespons
anim
reach
score
euthan
surviv
anim
bled
sacrif
day
pi
trachea
cloaca
swab
store
cold
tryptos
phosphat
broth
supplement
antibiot
medium
clarifi
lowspe
centrifug
supernat
harvest
aliquot
store
upon
thaw
trachea
cloaca
swab
sampl
bird
day
pool
viral
rna
extract
ml
use
magna
pure
lc
total
nucleic
acid
isol
kit
roch
subsequ
cdna
synthes
use
revers
primer
part
gene
amplifi
run
cycl
light
cycler
pcr
use
primer
revers
primer
presenc
taqman
fluoresc
probe
neg
posit
control
sampl
test
parallel
lower
limit
detect
determin
approxim
tcid
sampl
gave
inconclus
result
mean
gave
weak
signal
cycl
heatinactiv
immun
sera
chicken
blood
sampl
test
hemagglutin
inhibit
hi
activ
chicken
red
blood
cell
hemagglutin
unit
hau
aviet
addit
chicken
sera
test
hi
activ
use
hau
ng
recombin
solubl
trimer
ha
protein
end
recombin
protein
precomplex
antistreptag
antibodi
describ
mix
limit
dilut
chicken
sera
incub
chicken
red
blood
cell
red
button
format
score
evid
hemagglutin
antibodi
titer
express
reciproc
highest
serum
dilut
show
hi
immun
sera
prepar
mous
blood
sampl
treat
vcna
heatinactiv
min
test
hi
assay
use
hau
describ
total
antibodi
titer
determin
use
specif
elisa
end
nunc
maxisorp
plate
coat
mg
per
well
incub
limit
dilut
chicken
mous
sera
extens
wash
plate
incub
goatantichicken
goatantimous
antibodi
conjug
hrp
peroxidas
activ
visual
use
tetramethylbenzidin
substrat
biofx
elisa
reader
biotek
read
od
nm
od
valu
dilut
sampl
logarithm
phase
curv
plot
order
express
solubl
trimer
subtyp
ha
mammalian
cell
ectodomaincod
sequenc
first
clone
appropri
express
vector
vector
use
preced
signal
peptideencod
sequenc
allow
effici
secret
recombin
protein
follow
sequenc
code
isoleucinezipp
trimerizaton
motif
streptag
ii
latter
purif
purpos
fig
express
ectodomain
achiev
transient
transfect
express
plasmid
hek
cell
express
secret
protein
verifi
subject
cell
cultur
supernat
gel
electrophoresi
follow
western
blot
use
antibodi
direct
streptag
ii
fig
result
show
recombin
protein
could
readili
detect
cell
cultur
supernat
transfect
cell
express
plasmid
mock
transfect
secret
protein
purifi
singl
step
protocol
use
streptactin
sepharos
bead
protein
yield
vari
mg
recombin
protein
per
ml
cell
cultur
medium
purif
protein
cell
cultur
supernat
oligomer
state
protein
analyz
gel
filtrat
column
chromatographi
fig
bulk
protein
elut
veloc
oligom
minor
fraction
found
aggreg
void
volum
trimer
natur
oligom
confirm
use
bluen
gel
electrophoresi
follow
western
blot
fig
prepar
heatdenatur
increas
time
period
prior
electrophoresi
initi
trimer
ha
speci
dissoci
dimer
monom
biolog
activ
purifi
studi
use
solid
phasebind
assay
sialyl
blood
glycoprotein
fetuin
bind
measur
mean
hrp
conjug
antistreptag
ii
antibodi
detail
materi
method
section
prepar
exhibit
concentr
depend
bind
fetuin
bind
sialic
aciddepend
bind
observ
fetuin
treat
neuraminidas
vcna
fig
conclus
biolog
activ
effici
produc
use
mammalian
express
system
readili
purifi
examin
immunogen
potenti
vaccin
first
experi
chicken
perform
chicken
vaccin
twice
day
im
mg
stimuneadjuv
challeng
week
later
init
inocul
lethal
dose
aviet
viru
anoth
bird
mockvaccin
serv
challeng
control
shown
fig
boost
vaccin
mg
confer
complet
protect
none
vaccin
chicken
die
show
symptom
indic
influenzarel
diseas
wherea
mockvaccin
chicken
succumb
within
day
serolog
analysi
show
none
mockvaccin
anim
contain
antibodi
determin
specif
elisa
fig
contrast
immun
anim
demonstr
appreci
level
ha
antibodi
alreadi
singl
immun
level
increas
boost
total
antibodi
level
correl
nice
hi
titer
fig
mockvaccin
chicken
hi
titer
detect
limit
hi
antibodi
titer
observ
boost
reach
maximum
minimum
appar
still
suffici
protect
anim
lethal
challeng
interestingli
bird
develop
hi
antibodi
titer
equal
higher
alreadi
three
week
first
vaccin
addit
hi
titer
also
determin
use
rather
viru
hemagglutin
agent
gave
essenti
similar
result
compar
fig
demonstr
reliabl
assay
summari
result
show
chicken
vaccin
twice
protect
lethal
challeng
hi
titer
observ
suggest
one
vaccin
might
alreadi
suffici
confer
protect
hpai
result
prompt
us
determin
minim
dose
requir
confer
protect
examin
whether
singl
dose
could
alreadi
suffici
second
vaccinationchalleng
experi
chicken
thu
vaccin
mg
either
twice
challeng
four
week
later
infect
lethal
dose
aviet
describ
result
shown
fig
mockvaccin
bird
succumb
infect
within
day
vaccin
twice
dose
mg
suffici
protect
chicken
mortal
chicken
surviv
dose
mg
similarli
administ
fig
interestingli
also
singl
vaccin
could
induc
suffici
immun
protect
chicken
lethal
infect
fig
dose
mg
given
one
chicken
die
protect
wherea
dose
mg
protect
bird
even
singl
dose
mg
chicken
protect
death
serolog
analysi
show
protect
lethal
challeng
correl
well
observ
antibodi
level
determin
elisa
fig
hi
assay
fig
assay
reveal
dosedepend
antibodi
respons
substanti
enhanc
booster
immun
rel
high
ha
antibodi
level
observ
two
immun
even
lower
dose
except
two
anim
one
surviv
challeng
fig
also
singl
immun
signific
antibodi
level
measur
except
low
dose
group
anim
hardli
measur
elisa
titer
consist
anim
succumb
challeng
also
one
anim
die
singl
immun
mg
detect
antibodi
essenti
result
elisa
obtain
hi
assay
use
hemagglutin
agent
fig
thu
anim
succumb
lethal
challeng
singl
immun
also
exhibit
lowest
hi
titer
analyz
whether
vaccin
decreas
prevent
chicken
shed
challeng
viru
practic
reason
viru
shed
analyz
quantit
rt
pcr
rather
measur
infecti
viru
titer
end
trachea
cloaca
swab
taken
chicken
vaccin
dose
titrat
experi
fig
day
challeng
inocul
tracheal
cloacal
swab
sampl
chicken
particular
day
pool
presenc
viral
rna
pool
swab
analyz
use
quantit
rt
pcr
assay
detect
gene
result
shown
tabl
chicken
receiv
booster
vaccin
bird
receiv
lowest
amount
antigen
test
posit
notabl
two
anim
develop
lowest
specif
antibodi
titer
fig
one
anim
surviv
challeng
viru
shed
could
detect
bird
although
swab
gave
inconclus
result
chicken
vaccin
anim
die
test
posit
none
bird
vaccin
mg
test
posit
chicken
vaccin
lower
dose
surviv
two
test
posit
day
pi
conclus
vaccin
bird
could
control
lethal
hpai
challeng
infect
exhibit
minimum
viru
shed
final
examin
whether
would
also
confer
protect
mice
therefor
group
mice
vaccin
either
day
twice
day
mg
adjuv
stimun
challeng
three
week
later
intranas
inocul
ld
aviet
nam
percentag
mice
surviv
infect
median
clinic
score
bodi
weight
per
group
observ
challeng
inocul
shown
fig
mockvaccin
mice
succumb
infect
euthan
day
pi
mice
show
sever
clinic
sign
includ
respiratori
distress
signific
weight
loss
continu
anim
die
booster
vaccin
provid
protect
lethal
dose
aviet
none
mice
show
signific
sign
diseas
bodi
weight
remain
constant
singl
vaccin
protect
mice
diseas
concurr
weight
loss
yet
mice
surviv
mice
start
recov
day
pi
onward
demonstr
regain
bodi
weight
fig
fig
show
prechalleng
antibodi
level
individu
serum
sampl
determin
elisa
antibodi
could
detect
vaccin
anim
howev
singl
immun
level
remain
low
compar
anim
receiv
booster
vaccin
result
essenti
confirm
determin
hi
titer
serum
sampl
except
one
anim
serum
demonstr
high
level
autoagglutin
mice
display
high
hi
titer
vaccin
twice
low
hi
titer
vaccin
thu
mice
vaccin
twice
protect
lethal
challeng
hpai
singl
vaccin
provid
partial
protect
differ
protect
correl
observ
serum
hi
titer
despit
theunderstandableattent
drawn
past
year
media
scientif
commun
new
pandem
influenza
viru
larg
influenza
threat
continu
pose
hpai
hpai
found
wild
bird
germani
china
mongolia
russion
feder
sever
outbreak
viru
poultri
report
viet
nam
hong
kong
nepal
india
bangladesh
egypt
lao
dpr
cambodia
remain
endem
larg
area
indonesia
year
also
dozen
confirm
human
case
report
timelin
major
event
http
wwwwhointcsrdiseaseavianinfluenza
aitimelineenindexhtml
even
though
viru
far
remain
restrict
abil
infect
human
initi
effici
humantohuman
transmiss
persist
spread
among
wild
bird
poultri
hold
continu
risk
emerg
pandem
strain
threat
reduc
vaccin
poultri
would
limit
propag
viru
minim
risk
birdtohuman
transmiss
addit
case
human
pandem
would
emerg
would
immedi
need
effect
reliabl
vaccin
match
pandem
strain
present
studi
evalu
vaccin
potenti
recombin
solubl
protein
protect
chicken
mice
lethal
infect
hpai
recombin
ha
vaccin
short
develop
cycl
prove
protect
singl
immun
natur
host
booster
vaccin
need
confer
complet
protect
mammalian
model
addit
induc
immun
prevent
viral
shed
chicken
promis
result
warrant
research
develop
recombin
solubl
ha
fast
safe
effect
altern
vaccin
influenza
virus
well
recombin
ha
express
cassett
construct
ha
protein
produc
secret
cell
high
yield
bioactiv
trimer
import
oligomer
state
ha
protein
induct
neutral
antibodi
recent
demonstr
highmolecularweight
oligom
trimer
monom
found
effici
induc
neutral
antibodi
mice
differ
attribut
preferenti
induct
antibodi
epitop
present
monomer
trimer
form
solubl
recombin
ha
trimer
purifi
use
metal
affin
chromatographi
follow
ionexchang
chromatographi
previou
studi
use
protocol
base
streptag
system
protein
streptag
exhibit
high
affin
toward
streptactin
engin
form
streptavidin
exploit
highli
specif
interact
streptag
protein
isol
one
step
furthermor
streptag
elut
gentl
physiolog
condit
especi
suit
gener
nativ
protein
characterist
case
ha
may
contribut
abil
recombin
protein
induc
neutral
antibodi
efficaci
vaccin
first
studi
chicken
adjuv
stimun
waterinoil
adjuv
also
known
specol
protein
formul
induc
immun
complet
protect
lethal
challeng
administr
two
dose
mg
dose
importantli
vaccin
prepar
also
protect
chicken
singl
immun
chicken
protect
vaccin
mg
protect
use
mg
similar
ha
dose
previous
need
protect
chicken
vaccin
prepar
consist
full
length
ha
protein
purifi
insect
cell
cultur
infect
recombin
baculoviru
express
gene
emulsifi
waterinoil
adjuv
result
consist
observ
mammalian
cellproduc
ha
trimer
elicit
similar
level
neutral
antibodi
trimer
ha
produc
insect
cell
efficaci
vaccin
prepar
furthermor
demonstr
absenc
viral
rna
protect
bird
would
impli
vaccin
flock
pose
barrier
spread
circul
viru
convent
influenza
vaccin
requir
two
vaccin
round
produc
antibodi
titer
suffici
high
confer
full
protect
chicken
regard
vaccin
sha
provid
potenti
advantag
vaccin
approach
howev
product
cost
per
dose
sha
compar
eggcultur
inactiv
wholeviru
vaccin
might
higher
even
though
recombin
protein
express
mammalian
cell
cultur
system
shown
highli
scalabl
product
express
level
order
gram
protein
per
liter
sha
vaccin
could
howev
econom
feasibl
epidem
situat
million
chicken
vaccin
individu
provid
singl
prevent
vaccin
would
suffic
moreov
vaccin
flock
hous
endang
region
rapidli
achiev
state
protect
immun
may
particularli
valuabl
featur
event
pandem
viru
transmiss
cycl
need
interrupt
soon
possibl
risk
exposur
farmer
veterinarian
peopl
monitor
team
potenti
zoonot
hpai
limit
upmost
extent
efficaci
vaccin
also
studi
mice
vaccin
prepar
complet
protect
lethal
challeng
dose
immun
singl
dose
result
surviv
differ
protect
level
correl
observ
titer
anim
sera
dose
mg
receiv
mice
least
compar
rel
bodi
weight
dose
confer
complet
protect
chicken
singl
immun
mg
result
appear
suggest
effect
confer
protect
immun
respons
chicken
mice
reason
appar
discrep
unclear
warrant
investig
studi
far
use
solubl
ha
trimer
vaccin
prepar
mice
much
less
protect
challeng
observ
two
immun
although
trimer
produc
latter
studi
differ
one
use
respect
trimer
motif
foldon
vs
trimer
motif
purif
tag
tag
vs
strep
tag
ii
differ
like
explain
differ
adjuv
use
alum
vs
stimun
alum
known
induc
low
antibodi
titer
use
subunit
vaccin
stimun
report
gener
longlast
function
antibodi
respons
stimun
howev
licens
human
use
conclus
shown
protein
produc
mammalian
cell
elicit
protect
immun
respons
mice
chicken
adjuv
stimun
chicken
protect
lethal
challeng
also
shed
viru
day
post
infect
recombin
ha
vaccin
manufactur
high
yield
rel
short
lead
time
offer
attract
altern
vaccin
strategi
allow
rapid
respons
circul
potenti
pandem
influenza
virus
